Alliance Pharma PLC Interim Dividend Timetable - Record Date (6072Y)
September 10 2015 - 2:01AM
UK Regulatory
TIDMAPH
RNS Number : 6072Y
Alliance Pharma PLC
10 September 2015
For Immediate Release 10 September 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Interim Dividend Timetable - Record Date
In the announcement of its interim results for the six months
ended 30 June 2015 on 9 September 2015, the Company announced that
in relation to its interim dividend of 0.366 pence per share, the
record date will be 21 December 2015.
The Company would like to clarify that the record date for its
interim dividend will in fact be 18 December 2015 and not 21
December 2015. All other details relating to the Company's interim
dividend remain as disclosed in the announcement on 9 September
2015.
Enquiries:
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane Glover
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie
Barnfield
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAXNNEFFSEFF
(END) Dow Jones Newswires
September 10, 2015 02:01 ET (06:01 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024